FDA Media Alert Detail

Drug Shortage

FDA Drug Shortage: Methotrexate Sodium Injection

  • U.S. Food and Drug Administration
  • August 24, 2026
  • ID: shortage-methotrexate-sodium-injection-hospira-inc-a-pfizer-company-61703-350-10

Drug Shortage Details

Generic NameMethotrexate Sodium Injection
Manufacturer / CompanyHospira, Inc., a Pfizer Company
Therapeutic CategoryRheumatology, Oncology
Availability StatusAvailable
Status (FDA list)Current
NDC Package Code61703-350-10
Presentation & Dosage Form

Methotrexate Sodium, Injection, 50 mg/2 mL (25 mg/mL) (NDC 61703-350-10)

Manufacturer Contact Info

844-646-4398


Content syndicated from the U.S. Food and Drug Administration (FDA) Drug Shortages Database.